“Nobiletin Acts As a Potential Anticancer Agent Against Osteosarcoma by Regulating ERK and AKT Signaling Pathways”. 2014. Bangladesh Journal of Pharmacology 9 (3): 406-12. https://doi.org/10.3329/bjp.v9i3.19567.